Vantis Vascular
San Jose, US · Founded 2018 · Delaware corporation
Vantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter> <parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter> <parameter name="hq_city">San Jose
Founders & leadership
Competitors · 9
by search overlapCompanies competing with Vantis Vascular for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$18.6MraisedJul 2026 · 123 investors · OtherRule 506(b)
- Tim FischellExecutive Officer, Director
- Frank SaltielExecutive Officer, Director
- Len PinchukDirector
- Jason TurnerExecutive Officer, Director
- Marc MonahanExecutive Officer
- Mike MirizziExecutive Officer
- Gary McCordExecutive Officer
- Offering amount
- $21.5M
- Amount sold
- $18.6M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.3MraisedOct 2024 · 114 investors · OtherRule 506(b)
- Len PinchukDirector
- Gary McCordExecutive Officer
- Tim FischellExecutive Officer, Director
- Marc MonahanExecutive Officer
- Mike MirizziExecutive Officer
- Jason TurnerExecutive Officer, Director
- Frank SaltielExecutive Officer, Director
- Offering amount
- $22.2M
- Amount sold
- $14.3M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedFeb 2022 · 73 investors · OtherRule 506(b)
- Frank SaltielExecutive Officer, Director
- Jason TurnerExecutive Officer, Director
- Len PinchukDirector
- Tim FischellExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $7M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$503.5KraisedSep 2021 · 17 investors · OtherRule 506(b)
- Frank SaltielExecutive Officer, Director
- Tim FischellExecutive Officer, Director
- Len PinchukDirector
- Offering amount
- $800K
- Amount sold
- $503.5K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$700KraisedDec 2020 · 20 investors · OtherRule 506(b)
- Len PinchukDirector
- Frank SaltielExecutive Officer, Director
- Tim FischellExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $700K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$485KraisedDec 2018 · 14 investors · OtherRule 506(b)
- Tim FischellExecutive Officer, Director
- Frank SaltielExecutive Officer, Director
- Len PinchukDirector
- Offering amount
- $1.8M
- Amount sold
- $485K
- Minimum investment
- $25K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.